As more and more pharmaceutical companies launch social networking platforms associated with their brands, some will allow users (consumers, patients, and physicians) to post comments as part of ongoing discussions about their drugs and/or the conditions these drugs treat. Recent pharma experience with social media discussions demonstrates how important it is to properly manage online communities.
In public comments made to the FDA, LiveWorld, Inc. -- a leading global social network marketing agency that develops, operates and moderates private label social network sites - said "Moderation of user content related to healthcare subjects in social networks is central to the current discussion." Pharma Marketing News had an opportunity to interview Jenna Woodul, LiveWorld's EVP and Chief Community Officer, about how pharma companies can manage their social media interactions using technology and "credentialed participants" for moderating and managing online discussions.
This article presents a summary of that conversation plus some results of a recent survey of readers regarding moderation best practices.
Read this article now. It's FREE...
- What Sanofi-Aventis Learned from Its FaceBook Experience
- The Value of Discussion
- To Moderate or Not to Moderate?
- Survey Results
- A Strategy for Community Growth
Download PDF file